2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS 1030825-20-7 Ubunyulu ≥98.0% (HPLC)

Inkcazelo emfutshane:

2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene

CAS: 1030825-20-7

Imbonakalo: I-White okanye i-Off-White Powder

Ubunyulu: ≥98.0% (HPLC)

I-API ephakathi (i-CAS: 842133-18-0) kunyango lwe-Type 2 Diabetes Mellitus

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

AbaPhakathi abaNxulumene noBonelelo loMvelisi:
I-4-Fluorophenylboronic Acid CAS: 1765-93-1
I-2-(4-Fluorophenyl)thiophene CAS: 58861-48-6
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS: 32384-65-9
5-Iodo-2-Methylbenzoic Acid CAS 54811-38-0
2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS: 1030825-20-7
I-2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS: 898566-17-1
CAS: 842133-18-0
CAS: 928672-86-0

Iipropati zeMichiza:

Igama leMchiza	2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene
Inombolo yeCAS	1030825-20-7
Inombolo yeCAT	RF-PI234
Ubume beStokhwe	Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram
Ifomula yeemolekyuli	I-C18H14BrFS
Ubunzima beMolekyuli	361.27
Indawo yokunyibilika	103℃
Ukuxinana	1.388
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe okanye oMhlophe
Ubunyulu / Indlela yokuHlalutya	≥98.0% (HPLC)
Ilahleko ekomisweni	≤1.00%
Intsalela ekutshisweni	≤0.50%
Iintsimbi ezinzima	≤20ppm
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	I-API ephakathi (CAS: 842133-18-0)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-2-(5-Bromo-2-Methylbenzyl) -5- (4-Fluorophenyl) thiophene (CAS: 1030825-20-7) kunye nomgangatho ophezulu.Yonaliphakathi ngokuqhelekileyo kwi-synthesis ye-API (CAS: 461432-26-8).I-API (i-CAS: i-461432-26-8) iyeza elitsha le-antidiabetic eliphuhliswe ngokudibeneyo yi-Bristol-Myers Squibb kunye ne-AstraZeneca, evunyiweyo yi-Arhente ye-European Medicines Agency (EMA) ngoNovemba 12, 2012. Kwakhona i-SGLT2 inhibitor yokuqala evunyiweyo. unyango lwesifo sikashukela sohlobo lwe-II, ukuba lukhetho olubalulekileyo kunyango lwesifo sikashukela, kwaye lusetyenziselwa ukuphucula ukulawulwa kwe-glycemic njengento edibeneyo yokutya kunye nokuzivocavoca kubantu abadala abanesifo sikashukela sohlobo lwe-II.